Axiom Investment Management’s Boston Scientific BSX Stock Holding History

Axiom Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Buy	4,223 +1,359	+47%	+$73.8K	0.12%	119
2026 Q1	$180K	Buy	+2,864	New	+$229K	0.14%	114
2022 Q4	–	Sell	-3,727	Closed	-$143K	–	135
2022 Q3	$143K	Buy	+3,727	New	+$150K	0.29%	74
2019 Q3	–	Sell	-21,458	Closed	-$925K	–	242
2019 Q2	$925K	Buy	21,458 +90	+0.4%	+$3.46K	0.17%	149
2019 Q1	$820K	Buy	21,368 +950	+5%	+$36.3K	0.16%	154
2018 Q4	$722K	Buy	+20,418	New	+$741K	0.15%	153

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Axiom Investment Management's BSX Position: Q2 2026 in Review

Axiom Investment Management increased its Boston Scientific (BSX) stake by 47% in Q2 2026, buying an estimated $73.8K and bringing the position to 4,223 shares worth $180K. The position accounts for 0.12% of the portfolio, ranked #119.

Axiom Investment Management first reported a position in BSX in Q4 2018 and has held it in 6 quarters since. The position peaked at $925K in Q2 2019. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Axiom Investment Management held 4,223 shares of Boston Scientific worth $180K as of Q2 2026.
Axiom Investment Management bought 1,359 Boston Scientific shares in Q2 2026, an estimated $73.8K.
Boston Scientific made up 0.12% of Axiom Investment Management's portfolio in Q2 2026, its #119 holding.
Axiom Investment Management first reported a position in Boston Scientific in Q4 2018 and has held it in 6 quarters since.
Axiom Investment Management's Boston Scientific position peaked at $925K in Q2 2019.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.